710 related articles for article (PubMed ID: 29518493)
21. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
Pan W; Kang Y
Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
[TBL] [Abstract][Full Text] [Related]
22. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
23. The impact of gut microbiota on kidney function and pathogenesis.
Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
[TBL] [Abstract][Full Text] [Related]
24. Maternal Adenine-Induced Chronic Kidney Disease Programs Hypertension in Adult Male Rat Offspring: Implications of Nitric Oxide and Gut Microbiome Derived Metabolites.
Hsu CN; Yang HW; Hou CY; Chang-Chien GP; Lin S; Tain YL
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008046
[TBL] [Abstract][Full Text] [Related]
25. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease.
Onal EM; Afsar B; Covic A; Vaziri ND; Kanbay M
Hypertens Res; 2019 Feb; 42(2):123-140. PubMed ID: 30504819
[TBL] [Abstract][Full Text] [Related]
27. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
[TBL] [Abstract][Full Text] [Related]
28. Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.
Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
Nutrients; 2017 May; 9(5):. PubMed ID: 28498348
[TBL] [Abstract][Full Text] [Related]
29. The gut microbiota and its relationship with chronic kidney disease.
Plata C; Cruz C; Cervantes LG; Ramírez V
Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
[TBL] [Abstract][Full Text] [Related]
30. Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD.
Briskey D; Tucker PS; Johnson DW; Coombes JS
Nitric Oxide; 2016 Jul; 57():64-70. PubMed ID: 27164294
[TBL] [Abstract][Full Text] [Related]
31. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
[TBL] [Abstract][Full Text] [Related]
32. Alterations of intestinal barrier and microbiota in chronic kidney disease.
Sabatino A; Regolisti G; Brusasco I; Cabassi A; Morabito S; Fiaccadori E
Nephrol Dial Transplant; 2015 Jun; 30(6):924-33. PubMed ID: 25190600
[TBL] [Abstract][Full Text] [Related]
33. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
Black AP; Cardozo LF; Mafra D
Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
[TBL] [Abstract][Full Text] [Related]
34. Could physical exercise help modulate the gut microbiota in chronic kidney disease?
Esgalhado M; Borges NA; Mafra D
Future Microbiol; 2016 May; 11():699-707. PubMed ID: 27159232
[TBL] [Abstract][Full Text] [Related]
35. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
Mafra D; Lobo JC; Barros AF; Koppe L; Vaziri ND; Fouque D
Future Microbiol; 2014; 9(3):399-410. PubMed ID: 24762311
[TBL] [Abstract][Full Text] [Related]
36. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease.
Mafra D; Borges N; Alvarenga L; Esgalhado M; Cardozo L; Lindholm B; Stenvinkel P
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818761
[TBL] [Abstract][Full Text] [Related]
37. The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
Aron-Wisnewsky J; Clément K
Nat Rev Nephrol; 2016 Mar; 12(3):169-81. PubMed ID: 26616538
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota, hypertension and chronic kidney disease: Recent advances.
Sircana A; De Michieli F; Parente R; Framarin L; Leone N; Berrutti M; Paschetta E; Bongiovanni D; Musso G
Pharmacol Res; 2019 Jun; 144():390-408. PubMed ID: 29378252
[TBL] [Abstract][Full Text] [Related]
40. Gut Microbiota and Cardiovascular Uremic Toxicities.
Velasquez MT; Centron P; Barrows I; Dwivedi R; Raj DS
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29997362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
